Dr. Grover brings over 25 years of experience in leading healthcare innovation, entrepreneurship, and strategic fundraising. An immunologist by training, he has worked with the National Institutes of Health, Scripps Research, and as a board member of the American Nutrition Association. He was also an adjunct professor at the J. Craig Venter Institute, where he shared his expertise in immunology, genetics, and molecular biology.
A serial entrepreneur and futurist, Dr. Grover advises companies advancing longevity-focused healthcare, including regenerative medicine, pharmaceuticals, and medical devices. He has guided venture capital funds and family offices in healthcare investment strategies.
Dr. Grover has been instrumental in helping launch innovative companies and advising startups through platforms like the UCSD Entrepreneur Challenge and IndieBio. He co-founded a nutraceutical company offering advanced anti-inflammatory products, supporting product development, strategic, fund raising, partnerships, marketing, and compliance.
His research has been published in top journals including Science, PNAS, JAMA, and Nature Reviews. He has isolated molecules from plants with therapeutic potential. He holds multiple patents and at age 26 he discovered a novel antibacterial molecule effective against drug-resistant tuberculosis.
Dr. Grover earned his M.S. from the Indian Institute of Technology, Delhi, and Ph.D. from the Central Drug Research Institute. He completed his postdoctoral fellowship in Chemical Biology and Immunology at Scripps Research, USA. His work has been featured on PBS, DER SPIEGEL, and various global news platforms.
